ABACUS BIOSCIENCE
Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers. It provides a broad-based platform that can plug and play with multiple cancer or viral antigens.
ABACUS BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.abacusbioscience.com
Total Employee:
1+
Status:
Active
Founder
Official Site Inspections
http://www.abacusbioscience.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Abacus Bioscience"
Abacus Bioscience
Extending The Immunotherapy Frontier. First-in-Class Active Immunotherapies that overcome immune tolerance to treat cancer and chronic infectionSee details»
Abacus Bioscience - Crunchbase Company Profile & Funding
Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers. It provides a broad-based platform that can plug and play with multiple …See details»
ABACUS BIOSCIENCE INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ABACUS BIOSCIENCE INC of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
Abacus Bioscience Company Profile | Management and Employees …
Www.abacusbioscience.com Abacus Bioscience Profile and History Abacus Bioscience specializes in first-in-class active immunotherapies designed to overcome immune tolerance …See details»
Abacus Bioscience Inc - LinkedIn
Abacus Bioscience Inc | 420 followers on LinkedIn. Expanding the Immunotherapy Frontier - developing novel treatments for cancer/antiviral diseases using a CD180 backbone | Abacus Bioscience is ...See details»
Company Summary Mission - Life Science Washington Institute
For additional Information Please Contact Alan Wahl, PhD, [email protected] Or Che-Leung Law, PhD, [email protected] February 2024 2022 Mission Activating …See details»
Abacus Bioscience Inc Information - RocketReach
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are …See details»
Abacus Bioscience - Overview, News & Similar companies
Abacus Bioscience contact info: Phone number: (425) 780-5613 Website: www.abacusbioscience.com What does Abacus Bioscience do? Abacus Bioscience …See details»
Portfolio | Sahsen
Abacus Bioscience, Inc. Pre-clinical immunotherapeutic drug development for cancer and antiviral diseases using a CD180 backbone. Abacus Bioscience, established in 2015 by Alan Wahl, …See details»
Abacus Bioscience - PitchBook
Abacus Bioscience General Information Description. Developer of novel immune treatments intended to assist in treating cancer and chronic viral diseases. The company's treatments are based upon the delivery of antigens capable of …See details»
Abacus Bioscience, Inc. - Drug pipelines, Patents, Clinical trials ...
Mar 7, 2025 Explore Abacus Bioscience, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Abacus Bioscience, Inc. - lswinstitute.org
Abacusbioscience.com / 206-755-4434 Technology A Platform: Immune modulation via ntigen-Presenting Cells Antibody-targeted APC control Selective TLR axis control of antigen …See details»
Abacus Bio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Abacus Bio. Use the PitchBook Platform to explore the full profile.See details»
Nextsource | Company Profile | Abacus Bioscience
Explore the company profile of Abacus Bioscience (abacusbioscience.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Crystal Structure of CD180/MD-1 Complex - Abacus Bioscience
CD180 has attributes of Toll-Like-Receptors, and it recognizes mycobacterial lipoproteins. CD180 is exclusively expressed on two classes of antigen-presenting cells (APCs), B Cells and …See details»
AbacusBio: About us
Your organization is unlike any other. But your most pressing challenges are familiar to us: Commercially-viable impact projects. You’re improving farming outcomes in the Global South: …See details»
AbacusBio opens a new office in Canada – AbacusBio
Jun 22, 2023 AbacusBio, a New Zealand-based, world-leading agri-science consultancy specialising in genetics, data science, economics, and digital tech, is about to launch a new …See details»
AbacusBio | International leader in genetic improvement
ICBF and the Irish cattle breeding industry have benefited greatly from the excellent work provided by AbacusBio over the last 20 years. Their expert technical skills and industry …See details»
Abacus Bioscience | VentureRadar
Abacus Bioscience is developing novel immunotherapeutic treatments for managing cncer and antiviral diseases using a CD180 backbone. ... Find out more about Abacus Bioscience, …See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to …See details»